|
Video: What is a Stock Split?
|
|
Miragen Therapeutics is a clinical-stage biopharmaceutical company discovering and developing proprietary RNA-targeted therapies with a focus on microRNAs and their role in diseases. Co.'s product candidates include: cobomarsen, which is for the treatment of patients with certain cancers that have elevated microRNA-155, including cutaneous T-cell lymphoma, and adult T-cell leukemia/lymphoma; remlarsen, which is for the potential treatment of patients with pathological fibrosis, including idiopathic pulmonary fibrosis; and MRG-110, which is for the treatment of heart failure, wound healing, and other ischemic disease. According to our MGEN split history records, MGEN has had 2 splits. | |
|
MGEN (MGEN) has 2 splits in our MGEN split history database. The first split for MGEN took place on May 16, 2001. This was a 11 for 10 split, meaning for each 10 shares of MGEN owned pre-split, the shareholder now owned 11 shares. For example, a 1000 share position pre-split, became a 1100 share position following the split. MGEN's second split took place on November 13, 2020. This was a 1 for 15 reverse split, meaning for each 15 shares of MGEN owned pre-split, the shareholder now owned 1 share. For example, a 1100 share position pre-split, became a 73.3333333333333 share position following the split.
When a company such as MGEN splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as MGEN conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the MGEN split history from start to finish, an original position size of 1000 shares would have turned into 73.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into MGEN shares, starting with a $10,000 purchase of MGEN, presented on a split-history-adjusted basis factoring in the complete MGEN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/10/2014 |
|
End date: |
01/19/2021 |
|
Start price/share: |
$64.35 |
|
End price/share: |
$23.01 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-64.24% |
|
Average Annual Total Return: |
-15.10% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3,575.89 |
|
Years: |
6.28 |
|
|
|
Date |
Ratio |
05/16/2001 | 11 for 10 | 11/13/2020 | 1 for 15 |
|
|